| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Boosted protease inhibitor monotherapy versus boosted protease inhibitor plus lamivudine dual therapy as second-line maintenance treatment for HIV-1-infected patients in sub-Saharan Africa (ANRS12 286/MOBIDIP): a multicentre, randomised, parallel, open-label, superiority trial
|
Ciaffi, Laura
|
|
2017
|
4 |
9 |
p. e384-e392
|
artikel
|
| 2 |
Divergent paths to the end of AIDS
|
The Lancet HIV,
|
|
2017
|
4 |
9 |
p. e375
|
artikel
|
| 3 |
Does HIV prematurely age the brain?
|
Brew, Bruce J
|
|
2017
|
4 |
9 |
p. e380-e381
|
artikel
|
| 4 |
Effect of ageing on neurocognitive function by stage of HIV infection: evidence from the Multicenter AIDS Cohort Study
|
Goodkin, Karl
|
|
2017
|
4 |
9 |
p. e411-e422
|
artikel
|
| 5 |
Effect of point-of-care CD4 cell count results on linkage to care and antiretroviral initiation during a home-based HIV testing campaign: a non-blinded, cluster-randomised trial
|
Desai, Mitesh A
|
|
2017
|
4 |
9 |
p. e393-e401
|
artikel
|
| 6 |
Efficacy, safety, and effect on sexual behaviour of on-demand pre-exposure prophylaxis for HIV in men who have sex with men: an observational cohort study
|
Molina, Jean-Michel
|
|
2017
|
4 |
9 |
p. e402-e410
|
artikel
|
| 7 |
Optimism and concern at IAS 2017
|
Mayer, Kenneth H
|
|
2017
|
4 |
9 |
p. e382-e383
|
artikel
|
| 8 |
PrEP on demand or every day?
|
Tan, Darrell Hoi-San
|
|
2017
|
4 |
9 |
p. e379-e380
|
artikel
|
| 9 |
Reprising the role of CD4 cell count in HIV programmes
|
Peeling, Rosanna W
|
|
2017
|
4 |
9 |
p. e377-e378
|
artikel
|
| 10 |
Viable dual therapy second-line antiretroviral regimen for Africa?
|
Munderi, Paula
|
|
2017
|
4 |
9 |
p. e376-e377
|
artikel
|
Tijdschrift beschrijving